66 results
Page 2 of 4
6-K
EX-99.1
nlacqih7
21 Nov 22
Sol-Gel Technologies Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:42pm
6-K
EX-99.1
ksah18b 12kz9ri0lc
3 Oct 22
Sol-Gel Technologies Appoints Michael Glezin Vice
8:05am
6-K
EX-99.1
b3p6fok4vrplhf
4 Aug 22
Sol-Gel Technologies Reports Second Quarter 2022 Financial Results and Provides Corporate Update
9:32am
6-K
EX-99.1
4es9 4bssh2l
13 May 22
Sol-Gel Technologies Reports First Quarter 2022 Financial Results and Provides Corporate Update
7:05am
6-K
EX-1.1
brl5i 3m2ys1scnwsywr
19 Apr 22
Open Market Sale Agreementsm
4:05pm
6-K
EX-5.1
4elre3e7
19 Apr 22
Open Market Sale Agreementsm
4:05pm
F-3
EX-5.1
1effjmw k5
7 Apr 22
Shelf registration (foreign)
5:30pm
F-3
3nb630iz kyfu
7 Apr 22
Shelf registration (foreign)
5:30pm
20-F/A
y5yvhi1tqn4up
7 Apr 22
Annual report (foreign) (amended)
4:06pm
6-K
EX-99.1
hquycpo
30 Mar 22
Sol-Gel Technologies Reports Full Year 2021 Financial Results and Corporate Developments
7:53am
6-K
EX-99.1
42zwsgvj1hqz
21 Dec 21
Sol-Gel Technologies Announces About Inflammatory Lesions of Rosacea
11:22am
6-K
EX-99.1
npgdqtsc
12 Nov 21
Sol-Gel Technologies Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Developments
12:00am
6-K
EX-99.1
ucuecmq
8 Nov 21
Sol-Gel Technologies Announces Sale of Generic Dermatology Portfolio to Partner
4:55pm
6-K
EX-99.1
vk2ehe9uhhe k4mj9bs
4 Aug 21
Sol-Gel Technologies Reports Second Quarter 2021 Financial Results and Highlights
7:16am
6-K
EX-99.1
zxcbrday
27 Jul 21
TWYNEO®, a once-daily cream treatment for acne vulgaris, is the first FDA‑approved fixed‑dose combination of tretinoin and benzoyl peroxide
10:39am
6-K
EX-99.2
1lvxbcafwzn0931z
28 Jun 21
Sol-Gel Technologies and Galderma announce exclusive licenses for the About Papulopustular Rosacea
8:14am